You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Chemical Analyzer System for In Situ and Real Time Surface Monitoring for Composition Control During Synthesis of Compound Semiconductor Films

    SBC: Staib Instruments, Inc.            Topic: A13AT011

    The area of thin film growth has progressed rapidly, producing many high performance new materials which require accuracy of their atomic composition to perform as expected. Any method to provide real time in situ information about the elemental composition of the growing surface is highly valuable for these new, complicated materials. Utilizing a new instrument design, the Phase I project team ...

    STTR Phase II 2014 Department of DefenseArmy
  2. Micromachined Probes for Measurement and Characterization of Terahertz Materials and Devices

    SBC: DOMINION MICROPROBES, INC.            Topic: A12aT022

    The objective of this phase II STTR program is twofold: (1) to design, prototype, and commercialize differential on-wafer probes for characterizing devices in the 140220 GHz and 220320 GHz bands, and (2) to engineer the geometry and material of the micromachined probe tip to enable robust, consistent, and low-resistance electrical contact to devices with various contact pad metallizations, includi ...

    STTR Phase II 2014 Department of DefenseArmy
  3. SoundTrak: A Data Acquisition and Analysis System for OSDB

    SBC: BARRON ASSOCIATES, INC.            Topic: NICHD

    DESCRIPTION provided by applicant Obstructive sleep disordered breathing OSDB is common in both children and adults and is recognized as having substantial health related consequences at all ages Laboratory polysomnography PSG is the gold standard for diagnosing OSDB but the procedure is not without problems Polysomnographic studies are complex invasive expensive not universally avail ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Biologically-Derived Targeted Antimicrobials for Textile Applications

    SBC: TECHULON, INC.            Topic: A14AT012

    Skin infections caused by bacteria represent a significant risk to wounded soldiers. The most common source of bacterial infection is found in the fabrics of clothing, boots, and gear worn by the warfighter. Reducing the risk of infection for soldiers by treating the source fabrics will lead to positive outcome and support medically-related activities in non-sterile environments encountered by t ...

    STTR Phase I 2014 Department of DefenseArmy
  5. High-Performance Magnesium Alloys and Composites by Efficient Vapor Phase Processing

    SBC: Directed Vapor Technologies International, Inc.            Topic: A14AT007

    The low density of magnesium makes it of interest for the development of advanced materials having high specific strength and stiffness. Current Mg applications, however, are limited by the performance and cost/quality relationships of existing Mg-alloy systems. One approach to obtain improved Mg alloys is through the development of new alloys and/or Mg-based composite materials that are enabled t ...

    STTR Phase I 2014 Department of DefenseArmy
  6. Bacteriocin Based Antimicrobials for Textile Applications

    SBC: Luna Innovations Incorporated            Topic: A14AT012

    Antimicrobial treatments have been incorporated in a number of textile products used by the U.S. Army to control odor and reduce skin irritation, thus improving the quality of life for the warfighters. Current textile treatment using chemically-derived antimicrobials such as metals (silver- and copper-based compounds), polyphenols, halamines and quaternary ammonium compounds can effectively kill o ...

    STTR Phase I 2014 Department of DefenseArmy
  7. A Rapid assay for RNA targeted drugs: Instrumentation Supplement

    SBC: NUBAD, LLC            Topic: 300

    DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals Combined these classes of drugs have annual sales worldwide of $ billion Antibiotics that target nucleic acids account for $ billion of the $ billion of sales annuall for all antibiotics an ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD, LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. CG-GRID: Computational Genetics Grid Resource for Interaction Discovery

    SBC: PARABON COMPUTATION, INC.            Topic: 400

    DESCRIPTION provided by applicant Advances in DNA sequencing technology have now made it practical and affordable to generate datasets containing millions of genetic attributes that can be tested for association with disease susceptibility The computational complexity of searching for genetic interactions over such high dimensional datasets imposes great challenges for genome wide associatio ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Reversal of Myocardial Infarction by Localized Stimulation

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTION provided by applicant Heart attacks i e myocardial infarction or MI occur in more than million patients annually Advances in pharmacological therapy have dramatically improved survival following the initial MI Consequently the number of patients with previous MI continues to increase and as a result put in jeopardy millions of patients for development of heart failure I ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government